FDA Approved: FUROSCIX — Supplemental Application (scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation)

View source ↗

Summary

Supplemental application for FUROSCIX (furosemide injection 80 mg/10 mL) seeking approval for a new or expanded indication or formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema Associated with Congestive Heart Failure
• Heart Failure
• Other Edema-related Conditions Treated with Diuretics

Drugs mentioned

• FUROSCIX (Furosemide injection 80 mg/10 mL)

Snippet

SUPPL AP for FUROSCIX (FUROSEMIDE INJECTION 80 MG/ 10 ML)